Atle Fund Management AB
An institutional investment manager in STOCKHOLM. Its Form 13F for the quarter ended Jun 30, 2026, filed Jul 24, 2026. SEC CIK 1381843.
- Reported value$371.7m
- Positions39
Holdings: 39 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| ELI Lilly & CoLLY | COM | 532457108 | 35.8 | 9.6% | 29,821 | Reduced−9,901 | |
| Merck & Co. IncMRK | COM | 58933Y105 | 24.3 | 6.5% | 189,357 | Added+155,504 | |
| Johnson & JohnsonJNJ | COM | 478160104 | 21.7 | 5.8% | 85,425 | Reduced−6,952 | |
| Abbvie IncABBV | COM | 00287Y109 | 16.2 | 4.4% | 64,325 | Reduced−43,856 | |
| CVS Health CorpCVS | COM | 126650100 | 15.1 | 4.1% | 146,102 | Added+122,329 | |
| Thermo Fisher Scientific CorpTMO | COM | 883556102 | 14.0 | 3.8% | 27,859 | Added+4,873 | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 13.7 | 3.7% | 73,077 | Reduced−544,168 | |
| Biogen IncBIIB | COM | 09062X103 | 13.6 | 3.6% | 62,781 | New+62,781 | |
| Neurocrine Biosciences IncNBIX | COM | 64125C109 | 12.3 | 3.3% | 72,898 | Reduced−16,787 | |
| Mirum Pharmaceuticals IncMIRM | COM | 604749101 | 11.8 | 3.2% | 100,807 | Reduced−94,961 | |
| Alkermes plc | SHS | G01767105 | 11.2 | 3.0% | 213,329 | Reduced−29,144 | |
| Ionis Pharmaceuticals IncIONS | COM | 462222100 | 10.9 | 2.9% | 137,131 | Added+109,258 | |
| Beone Medicines Ltd-AdrONC | SPONSORED ADS | 07725L102 | 10.0 | 2.7% | 35,180 | Reduced−6,537 | |
| Intuitive Surgical IncISRG | COM NEW | 46120E602 | 9.8 | 2.6% | 24,656 | Reduced−46,195 | |
| Stryker CorporationSYK | COM | 863667101 | 9.5 | 2.6% | 30,283 | Added+3,448 | |
| Vertex Pharmaceuticals IncVRTX | COM | 92532F100 | 9.5 | 2.6% | 19,131 | Reduced−3,853 | |
| Edwards Lifesciences CorpEW | COM | 28176E108 | 9.3 | 2.5% | 103,230 | Reduced−3,288 | |
| Bridgebio Pharma IncBBIO | COM | 10806X102 | 9.3 | 2.5% | 124,707 | Added+13,344 | |
| Krystal Biotech, IncKRYS | COM | 501147102 | 8.9 | 2.4% | 24,019 | Reduced−13,560 | |
| Cencora IncCOR | COM | 03073E105 | 8.8 | 2.4% | 31,126 | Added+7,656 | |
| Newamsterdam Pharma Co NV | ORDINARY SHARES | N62509109 | 8.4 | 2.3% | 248,848 | Added+154,052 | |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 7.8 | 2.1% | 58,170 | Added+26,580 | |
| Incyte CorpINCY | COM | 45337C102 | 6.5 | 1.7% | 56,953 | Added+6,157 | |
| Irhythm Technologies IncIRTC | COM | 450056106 | 6.4 | 1.7% | 54,102 | Added+31,780 | |
| Boston ScientifcBSX | COM | 101137107 | 6.2 | 1.7% | 146,381 | Added+105,949 | |
| Insmed IncINSM | COM PAR $.01 | 457669307 | 6.2 | 1.7% | 58,378 | Reduced−39,060 | |
| Tango Therapeutics IncTNGX | COM | 87583X109 | 6.2 | 1.7% | 198,557 | Added+168,642 | |
| Gilead Sciences IncGILD | COM | 375558103 | 5.8 | 1.6% | 46,142 | Reduced−1,825 | |
| Cardinal Health IncCAH | COM | 14149Y108 | 5.6 | 1.5% | 23,630 | Reduced−85,052 | |
| Oruka TherapeutiORKA | COM | 687604108 | 5.2 | 1.4% | 54,886 | New+54,886 | |
| Spyre Therapeutics IncSYRE | COM NEW | 00773J202 | 5.1 | 1.4% | 57,030 | Reduced−5,705 | |
| Dexcom IncDXCM | COM NEW | 252131107 | 4.8 | 1.3% | 71,846 | Reduced−512,486 | |
| Bicara Therapeutics IncBCAX | COM | 055477103 | 4.3 | 1.2% | 145,657 | Reduced−1,023,977 | |
| Ideaya Biosciences IncIDYA | COM | 45166A102 | 3.5 | 0.9% | 94,478 | Added+63,345 | |
| Celcuity IncCELC | COM | 15102K100 | 3.5 | 0.9% | 33,313 | Reduced−107,983 | |
| Disc Medicine IncIRON | COM | 254604101 | 3.2 | 0.9% | 43,682 | Reduced−63,573 | |
| Pyxis Oncology IncPYXS | COMMON STOCK | 747324101 | 2.9 | 0.8% | 966,459 | Added+769,423 | |
| Compass Therapeutics IncCMPX | COM | 20454B104 | 2.3 | 0.6% | 1,048,593 | Added+1,006,762 | |
| Jade BiosciencesJBIO | COM NEW | 008064206 | 2.0 | 0.5% | 88,556 | New+88,556 |
Sold out: 3 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Amgen IncAMGN | COM | 031162100 | 0.0 | 0.0% | 0 | Sold out−21,903 | |
| Soleno Therapeutics Inc | COM | 834203309 | 0.0 | 0.0% | 0 | Sold out−90,184 | |
| Universal Health Services IncUNH | COM | 91324P102 | 0.0 | 0.0% | 0 | Sold out−14,636 |
Source: SEC EDGAR, Form 13F-HR, accession 0001381843-26-000005 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.